KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Shares Outstanding (Diluted Average) (2016 - 2026)

Biocryst Pharmaceuticals filings provide 13 years of Shares Outstanding (Diluted Average) readings, the most recent being $218.6 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 5.75% to $218.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $218.6 million, a 5.75% increase, with the full-year FY2025 number at $218.6 million, up 5.75% from a year prior.
  • Shares Outstanding (Diluted Average) hit $218.6 million in Q4 2025 for Biocryst Pharmaceuticals, down from $219.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $219.9 million in Q3 2025 to a low of $177.3 million in Q1 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $189.0 million (2023), compared with a mean of $195.6 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): surged 112737.16% in 2021 and later grew 1.57% in 2023.
  • Biocryst Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $179.1 million in 2021, then rose by 3.79% to $185.9 million in 2022, then grew by 3.38% to $192.2 million in 2023, then rose by 7.54% to $206.7 million in 2024, then grew by 5.75% to $218.6 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $218.6 million (Q4 2025), $219.9 million (Q3 2025), and $217.6 million (Q2 2025) per Business Quant data.